Flash Finance

Apollo Hospitals Enterprise LimitedAPOLLOHOSPCorporate

Healthcare Medical Care Facilities Latest results: Mar 2026 14 quarters of data
Consolidated Standalone
₹7,890.00
MCap ₹113,446 Cr · P/E 76.0
Apollo Hospitals Enterprise Limited — Stock analysis & AI research Apollo Hospitals Enterprise Limited — Multibagger AI analysis Apollo Hospitals Enterprise Limited — Seasonality — best & worst months Apollo Hospitals Enterprise Limited — Technical indicators & charts Apollo Hospitals Enterprise Limited — Technical setup — score, trend, support & resistance Apollo Hospitals Enterprise Limited — Live exchange announcements
📋 High ROE Stocks📋 High Profit Growth Stocks📋 Stocks With Strong Quarterly Results📋 Large Cap Stocks List ⚖️ vs Max Healthcare⚖️ vs Aster DM 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹2,438 Cr
Sales · Mar 2026
+17.5% YoY
₹596 Cr
Operating Profit · Mar 2026
+14.3% YoY
24.4%
OPM % · Mar 2026
-2.8% YoY
₹382 Cr
Net Profit · Mar 2026
+14.6% YoY
₹26.60
EPS · Mar 2026
+14.8% YoY

📝 Apollo Hospitals Enterprise Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Apollo Hospitals Enterprise Limited reported revenue of ₹2,438 crore for the quarter ended March 2026 (Q4 FY26), up 17.5% from ₹2,075 crore in the same quarter last year, and up 3.1% sequentially over the December 2025 quarter.

Net profit rose 14.6% year-on-year to ₹382 crore, from ₹333 crore. Earnings per share (EPS) came in at ₹26.60.

Operating profit stood at ₹596 crore — an operating margin (OPM) of 24.4%, compared with 25.1% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Apollo Hospitals Enterprise Limited posted revenue of ₹9,326 crore, a growth of 13.7% over FY25, with a net profit of ₹1,492 crore (up 15.1% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹9,326 crore with a net profit of ₹1,492 crore.

Valuation snapshot

At the current price of ₹7,890.00, APOLLOHOSP has a market capitalisation of ₹113,446 crore and a trailing P/E of about 76.0.

Within the Medical Care Facilities industry, it is the largest of the 11 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 28.02%, foreign institutional investors (FIIs) 43.18%, domestic institutional investors (DIIs) 22.07%, the government 0.23%, public shareholders 6.49% of Apollo Hospitals Enterprise Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹113,446 Cr
Current Price ?
₹7,890.0
P/E ?
76.02above ind
Industry P/E ?
56.40
P/B ?
11.39
P/S ?
12.16
P/FCF ?
111.33
Enterprise Value ?
₹116,636 Cr
EV/EBITDA ?
50.09
PEG ?
6.34
Earnings Yield ?
1.6%
Dividend Yield ?
0.23%
Profitability & Returns
Sales (TTM) ?
₹9,326 Cr
OPM ?
25.0%
Profit after tax (TTM) ?
₹1,492 Cr
EPS (TTM) ?
₹103.79
ROCE ?
18.0%
ROE ?
15.0%
ROA ?
10.0%
Growth
Sales — latest qtr ?
₹2,438 Cr
PAT — latest qtr ?
₹382 Cr
YoY qtr sales growth ?
17.5%
YoY qtr profit growth ?
14.6%
Sales growth (3y) ?
13%
Sales growth (5y) ?
15%
Profit growth (3y) ?
12%
Profit growth (5y) ?
69%
Financial Health
Debt ?
₹3,190 Cr
Debt to Equity ?
0.32
Interest Coverage ?
7.6
Current Ratio ?
N/A
Ownership
Promoter holding ?
28.02%
Change in promoter holding ?
-1.32%
Pledged percentage ?
N/A
Market
Return 3 months ?
-10.6%
Return 6 months ?
2.5%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026 YoY % QoQ %
Sales 4,2641,6411,6881,8661,8241,8951,9372,1352,0552,0752,1682,3562,3642,438 +17.5% +3.1%
Operating Profit 505423418479450450471540512521546593594596 +14.3% +0.4%
Other Income 35431865524627121108923214110890 -1.7% -16.7%
Interest 10061616061696465626359586263 -0.2% +2.1%
Depreciation 15397939397115103108108130123122127128 -1.4% +0.9%
Profit Before Tax 266309282391344312332488449420397554502494 +17.6% -1.5%
Net Profit 162227214295263239252370342333307420384382 +14.6% -0.4%
EPS 10.6715.7814.8920.5018.2816.6117.5125.7123.7623.1821.3529.2026.6726.60 +14.8% -0.3%
OPM % 11.9% 25.8% 24.8% 25.7% 24.7% 23.8% 24.3% 25.3% 24.9% 25.1% 25.2% 25.2% 25.1% 24.4% -2.8% -2.8%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹8,203 Cr ₹9,326 Cr ₹9,326 Cr +13.7%
Operating Profit ₹2,045 Cr ₹2,328 Cr ₹2,328 Cr +13.9%
OPM % 24.93% 24.97% 24.97% +0.2%
NPM % 15.81% 16.00% 16.00% +1.2%
Other Income ₹348 Cr ₹372 Cr ₹372 Cr +6.9%
Depreciation ₹449 Cr ₹500 Cr ₹500 Cr +11.4%
Interest ₹254 Cr ₹241 Cr ₹241 Cr -5.1%
EBIT ₹1,596 Cr ₹1,828 Cr ₹1,828 Cr +14.6%
PBT ₹1,688 Cr ₹1,946 Cr ₹1,946 Cr +15.2%
Tax ₹204 Cr ₹342 Cr ₹342 Cr +67.0%
Net Profit ₹1,297 Cr ₹1,492 Cr ₹1,492 Cr +15.1%
EPS ₹90.16 ₹103.82 ₹103.82 +15.2%
Material Cost ₹1,143 Cr ₹1,813 Cr ₹1,813 Cr +58.6%
Employee Cost ₹823 Cr ₹1,245 Cr ₹1,245 Cr +51.3%
Extraordinary Items — ₹-11 Cr ₹-11 Cr —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 72727272 +0.0%
Reserves 6,8537,6398,6629,891 +14.2%
Borrowings 2,5203,2223,0903,190 +3.2%
Other Liabilities 1,3351,4721,5481,762 +13.8%
Total Liabilities 10,78012,40513,37214,914 +11.5%
Fixed Assets 5,0786,0326,3486,935 +9.2%
CWIP 96200306302 -1.3%
Investments 2,2172,6213,9114,893 +25.1%
Other Assets 3,3893,5532,8072,786 -0.7%
Total Assets 10,78012,40513,37214,914 +11.5%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 1,2241,1911,7422,059 +18.2%
Cash from Investing Activity -588-835-1,046-1,413 -35.1%
Cash from Financing Activity -779-297-739-537 +27.3%
Net Cash Flow -14359-43109 +353.5%
Free Cash Flow 8315728971,019 +13.6%
CFO/OP 91%85%103%109% +5.8%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 46413633 -8.3%
Inventory Days 19222122 +4.8%
Days Payable 124138134144 +7.5%
Cash Conversion Cycle -59-76-77-89 -15.6%
Working Capital Days 7364234 +1600.0%
ROCE % 16%15%16%18% +12.5%

👥 Shareholding (latest 6 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026 % Chg
Promoters 29.34%28.02%28.02%28.02%28.02%28.02% +0.0%
FIIs 43.49%44.20%43.54%42.62%41.50%43.18% +4.0%
DIIs 21.34%21.12%21.50%22.76%23.72%22.07% -7.0%
Government 0.23%0.23%0.23%0.23%0.23%0.23% +0.0%
Public 5.61%6.43%6.71%6.39%6.54%6.49% -0.8%
No. of Shareholders 1,41,0071,60,5561,78,6481,74,6101,74,2811,72,863 -0.8%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 APOLLOHOSP Apollo Hospitals ₹7,988.50 114,862 59.2 25,229 2,002 14.9% 7.9% 15.8% 33.1% 18.1% 32.9%
2 MAXHEALTH Max Healthcare ₹1,037.70 101,000 69.2 8,712 1,457 26.6% 16.7% 19.1% 34.1% 16.7% 4.9%
3 MANIPALHOS Manipal Health ₹710.85 93,504 — — — — — — — 28.2% -8.3%
4 FORTIS Fortis Healthcare ₹887.80 67,025 64.3 9,128 1,064 22.8% 11.7% 17.3% 31.4% 17.8% 44.1%
5 ASTERDM Aster DM ₹763.50 66,552 198.5 4,876 363 19.0% 7.5% 44.2% 138.8% 21.6% -68.9%
6 MEDANTA Global Health ₹1,445.60 38,846 69.8 4,683 553 20.9% 11.8% 19.4% 15.1% 26.5% -1.1%
7 NH Narayana Hrudayalaya ₹1,869.90 37,978 46.6 9,073 817 19.3% 9.0% 41.4% 1.9% 78.0% 5.4%
8 KIMS Krishna Institute ₹767.50 30,711 148.9 4,214 194 19.8% 4.6% 28.7% -41.5% 35.3% -56.0%
9 RAINBOW Rainbow Children's ₹1,450.00 14,710 51.6 1,820 290 31.6% 15.9% 12.4% 15.2% 33.2% 16.2%
10 GAUDIUMIVF Gaudium IVF ₹116.42 847 36.4 106 23 32.9% 21.8% — — 9.1% -42.2%
11 MOMSBELIEF Rays of Belief ₹223.00 466 — — — — — — — 136.4% 616.1%
❓ Frequently asked questions
What was Apollo Hospitals Enterprise Limited's revenue in Q4 FY26?
Apollo Hospitals Enterprise Limited reported revenue of ₹2,438 crore for the quarter ended March 2026 (Q4 FY26), up 17.5% from ₹2,075 crore in the same quarter last year, and up 3.1% sequentially over the December 2025 quarter.
What was Apollo Hospitals Enterprise Limited's net profit in Q4 FY26?
Net profit rose 14.6% year-on-year to ₹382 crore, from ₹333 crore. Earnings per share (EPS) came in at ₹26.60.
What is APOLLOHOSP's market capitalisation and P/E ratio?
At the current price of ₹7,890.00, APOLLOHOSP has a market capitalisation of ₹113,446 crore and a trailing P/E of about 76.0.
Who owns Apollo Hospitals Enterprise Limited? (shareholding pattern)
As of Sep 2026, promoters held 28.02%, foreign institutional investors (FIIs) 43.18%, domestic institutional investors (DIIs) 22.07%, the government 0.23%, public shareholders 6.49% of Apollo Hospitals Enterprise Limited.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI